Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

102
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
102
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

15.4K
Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
15.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

144
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
144
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

7.3K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.3K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

12.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
12.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

129
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polycythemia Vera Masked by Megaloblastic Anemia.

The Gulf journal of oncology·2024
Same author

A rare cause of respiratory failure in acute myeloid leukaemia patient.

Annals of hematology·2020
Same author

[Evaluation of preoperative nutritional status in visceral surgery Correlational study].

Journal de pharmacie de Belgique·2018
Same author

[Prevalence of pica in iron deficiency anemia in Marrakech (Morocco)].

Medecine et sante tropicales·2015
Same author

[Assessment of transfusion practice: assessing nurses' knowledge in transfusion medicine at Mohamed VI Hematology and Oncology Center of Marrakesh, Morocco].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2014
Same author

Bilateral sudden hearing loss following ABVD protocol.

Journal of cancer research and therapeutics·2014

Related Experiment Video

Updated: Oct 28, 2025

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.1K

[Non-Hodgkin cardiac lymphomas].

I Tazi1, A Benmoussa1, F Z Boufarissi1

  • 1Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.

Annales De Cardiologie Et D'Angeiologie
|July 18, 2021
PubMed
Summary

Cardiac non-Hodgkin lymphoma (CNHL) is a rare heart cancer. Early diagnosis via imaging and tissue analysis, followed by chemotherapy and radiotherapy, is crucial for improving patient outcomes.

Keywords:
ChemotherapyChimiothérapieDiagnosisDiagnosticImagerieImagingLymphome cardiaque primitifLymphome cardiaque secondairePrimary cardiac lymphomaRadiotherapyRadiothérapieSecondary cardiac lymphoma

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.8K

Related Experiment Videos

Last Updated: Oct 28, 2025

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.1K
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.8K

Area of Science:

  • Cardiology
  • Oncology
  • Hematology

Background:

  • Cardiac non-Hodgkin lymphoma (CNHL) is a rare extranodal lymphoma with a poor prognosis.
  • Secondary cardiac lymphoma is more common than primary cardiac lymphoma, frequently involving the right heart.
  • Diffuse B-cell lymphoma constitutes the majority of CNHL cases.

Purpose of the Study:

  • To summarize the key aspects of cardiac non-Hodgkin lymphoma.
  • To highlight diagnostic modalities and treatment strategies for CNHL.

Main Methods:

  • Review of existing literature on cardiac non-Hodgkin lymphoma.
  • Discussion of diagnostic tools such as echocardiography, MRI, and tissue biopsy.
  • Outline of treatment approaches including chemotherapy and radiotherapy.

Main Results:

  • CNHL diagnosis can be suggested by echocardiography and MRI.
  • Cytological examination of pericardial fluid or histological analysis of cardiac tissue is essential for definitive diagnosis.
  • Prompt diagnosis and early, individualized treatment are critical.

Conclusions:

  • Effective management of CNHL requires a multidisciplinary approach.
  • Chemotherapy, often containing anthracycline, combined with radiotherapy, represents the most effective treatment.
  • Early intervention is paramount for improving outcomes in cardiac non-Hodgkin lymphoma.